valrubicin has been researched along with Head and Neck Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, A; Hengesteg, A; Israel, M; Koseki, Y; Robbins, KT; Samant, S; Sweatman, TW; Wani, MK; Yarber, RH | 1 |
1 other study(ies) available for valrubicin and Head and Neck Neoplasms
| Article | Year |
|---|---|
Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Cricetinae; Doxorubicin; Head and Neck Neoplasms; Injections, Intralesional; Models, Animal; Tumor Cells, Cultured | 2000 |